Attempted Gene Therapy for Intractable Pain: Dexamethasone-Mediated Exogenous Control of β-Endorphin Secretion in Genetically Modified Cells and Intrathecal Transplantation
- 1 November 2000
- journal article
- Published by Elsevier in Experimental Neurology
- Vol. 166 (1) , 90-98
- https://doi.org/10.1006/exnr.2000.7491
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 31 references indexed in Scilit:
- Intrathecal delivery of CNTF using encapsulated genetically modifiedxenogeneic cells in amyotrophic lateral sclerosis patientsNature Medicine, 1996
- Neural transplantation and trophic factors in Parkinson's disease: special reference to chromaffin cell grafting, NGF support from pretransected peripheral nerve, and encapsulated dopamine-secreting cell grafting.Experimental Neurology, 1996
- The exogenous control of transfected c-fos gene expression and angiogenesis in cells implanted into the rat brainBrain Research, 1995
- Retrovirus‐Mediated Expression of an Artificial β‐Endorphin Precursor in Primary FibroblastsJournal of Neurochemistry, 1995
- TRANSPLANTATION IN HUMANS OF ENCAPSULATED XENOGENEIC CELLS WITHOUT IMMUNOSUPPRESSIONTransplantation, 1994
- Transplantation of Polymer Encapsulated Neurotransmitter Secreting Cells: Effect of the Encapsulation TechniqueJournal of Biomechanical Engineering, 1991
- Transplantation of neural tissue in polymer capsulesBrain Research, 1988
- Long Term Intrathecal Administration of Morphine: A Comparison of Bolus Injection via Reservoir with Continuous Infusion by Implanted PumpNeurosurgery, 1987
- Continuous intrathecal hydromorphone and clonidine for intractable cancer painJournal of Neurosurgery, 1986
- The formalin test: A quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and catsPain, 1977